What Pennsaid Treats

Pennsaid is a topical nonsteroidal anti-inflammatory drug (NSAID) formulated to address localized pain and physical limitations associated with certain joint conditions. Unlike oral medications that circulate throughout the entire body, this liquid solution is applied directly to the skin to deliver the active ingredient through the dermal layers to the affected area.

Main Uses

The primary use of Pennsaid is for the treatment of pain related to osteoarthritis. It is specifically designed for use on joints that are close to the surface of the skin, where the medication can more easily reach the site of inflammation.

• Osteoarthritis of the Knee: It is most commonly used to manage the symptoms of osteoarthritis in the knees. This includes treating the chronic pain that occurs as a result of the wearing down of protective cartilage within the joint.
• Localized Pain Relief: It serves as an option for patients who require relief from joint-specific discomfort and stiffness caused by degenerative joint disease.

Benefits

By delivering the medication topically, Pennsaid offers several therapeutic advantages for individuals managing chronic joint conditions:

• Targeted Delivery: The formulation allows the active medication to concentrate at the site of the pain. This direct application ensures that the treatment is focused on the specific joint requiring relief.
• Management of Inflammation: As an NSAID, the medication works by inhibiting the enzymes responsible for producing chemicals in the body that cause pain and inflammation. This helps to reduce the swelling and tenderness associated with osteoarthritic flares.
• Improved Physical Function: By reducing pain and stiffness, the medication can help individuals maintain better mobility and carry out daily physical activities with less discomfort.
• Lower Systemic Exposure: Because the medication is absorbed primarily through the skin at the application site, the amount of the drug that enters the bloodstream is significantly lower compared to oral NSAIDs. This can be a relevant factor for patients who are sensitive to the systemic effects of oral anti-inflammatory medications.

Pennsaid is officially indicated for use in adults for the pain of osteoarthritis of the knee. However, its use is strictly governed by regulatory rules linked to its classification as a Nonsteroidal Anti-inflammatory Drug (NSAID).

Absolute Contraindications

The medicine must not be used in the following populations, as officially documented:

• Patients with a known hypersensitivity to diclofenac or any components of the solution.
• Individuals with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
• Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
• Pregnant women starting at 30 weeks gestation (third trimester).

Restricted and Conditional Use

Official labeling defines specific groups that require caution or restricted use:

• Pediatric Use: Safety and effectiveness have not been established in children and adolescents.
• Geriatric Patients: Older adults must use with caution due to a higher risk for serious gastrointestinal and renal effects.
• Organ Function: Use should generally be avoided in patients with advanced renal disease or severe heart failure unless the anticipated benefits outweigh the risks.
• Comorbidity Risk: Patients with a prior history of GI bleeding or existing cardiovascular risk factors must be prescribed the medicine with extreme caution, as stated in regulatory documents.

The interaction profile for Pennsaid (diclofenac sodium topical solution) is defined by its potential for systemic absorption, leading to documented drug-drug interactions, particularly those characteristic of Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

High-Risk Combination Restrictions

Concurrent use with oral NSAIDs should be avoided due to a significantly increased risk of serious gastrointestinal (GI) events, and combination therapy is generally discouraged by regulatory authorities. Co-administration with aspirin (at analgesic doses) is similarly not recommended. Use is formally contraindicated in patients with a history of allergic-type reactions to aspirin or other NSAIDs.

Pharmacodynamic Effects and Monitoring

The use of Pennsaid with anticoagulants (such as warfarin) or other drugs that interfere with hemostasis (e.g., SSRIs, SNRIs) requires patient monitoring due to a heightened risk of serious bleeding. Co-administration with Methotrexate may also increase the risk of adverse effects.

Efficacy Alterations and Exposure

Diclofenac may diminish the antihypertensive effect of agents like ACE inhibitors, ARBs, and Beta-Blockers, and can reduce the natriuretic effect of diuretics. In patients who are elderly or volume-depleted, this combination with ACE inhibitors or ARBs may also lead to deterioration of renal function. Furthermore, use with Digoxin can increase the serum concentration of Digoxin.

Substance and Topical Use Restrictions

Alcohol consumption is a documented factor that increases the risk of GI bleeding. For application timing, other topical products (like sunscreen or lotions) must not be applied to the treated area until the Pennsaid solution is completely dry.

Targeting the Prostaglandin Synthesis Pathway

The drug functions as an inhibitor of the cyclooxygenase (COX) enzymes, particularly COX-2, which catalyzes the synthesis of prostaglandins and other eicosanoids that act as inflammatory mediators. By blocking the COX active sites, Diclofenac suppresses the formation of prostaglandins—such as Prostaglandin E2 ( PGE2)—at the tissue level. This interruption of the arachidonic acid cascade is the molecular foundation for the drug's effect.

Controlling Peripheral Nociceptor Sensitization

The reduction in local PGE2 levels directly impacts peripheral nociceptors by preventing the chemical sensitization that modulates their excitability. This suppression alters the responsiveness of the nerve endings to stimuli, affecting the local transmission of nociceptive signals and contributing to physiological adjustments in the tissue.

The Role of Localized Accumulation

The drug's specialized vehicle facilitates the passive diffusion of Diclofenac across the skin, enabling its accumulation and persistence in deep joint tissues, such as the synovial fluid. This targeted delivery mechanism concentrates the enzyme-inhibiting action where the inflammatory mediators are being generated, establishing the necessary inhibitory concentration within the affected tissue.

How to Use Pennsaid (Diclofenac Sodium Topical Solution 2%)

The use and administration of Pennsaid involves a specific process for its topical application to the affected area.

Administration Protocol

Entity	Standard Instruction
Route of Administration	Topical application to the affected knee(s) only.
Standard Dosing	40 mg of diclofenac sodium, equivalent to 2 pump actuations, per knee.
Frequency and Timing	Apply the dose 2 times a day (e.g., morning and evening).
Administration Site	The solution should be applied to the front, back, and sides of the entire knee.

---

Procedural and Handling Requirements

Proper use involves specific steps to ensure the intended dosage and delivery:

1. Preparation: Before the first use, the pump must be primed by fully depressing the pump mechanism four times and discarding the product dispensed. This is required to deliver the correct dose size.
2. Application: The dose should be applied to clean, dry skin. The solution is spread evenly over the entire affected knee area.
3. Post-Application Constraints: To avoid drug removal or dilution, hands should be washed thoroughly after administration. The application area should not be covered with an occlusive dressing or exposed to external heat. It is necessary to wait until the solution is completely dry before covering the knee with clothing or applying other topical products.

Population-Specific Guidance

The lowest effective dosage for the shortest duration possible is typically utilized, particularly in the geriatric population, consistent with individual treatment goals. If a dose is missed, it should be applied as soon as remembered, unless it is almost time for the next scheduled dose; in that event, the missed dose should be skipped.

Research Evidence / Overview of Studies for Pennsaid

Evidence for use in Osteoarthritis of the Knee

The primary research for the topical diclofenac solution was studied for use in osteoarthritis of the knee, a condition characterized by functional limitations. The core evidence consists of Randomized Controlled Trials (RCTs), studies typically used for initial regulatory evaluation. These RCTs were designed to be double-blind, where the topical solution was compared against an inactive liquid preparation (a vehicle control). Research examined outcomes related to physical discomfort in adult populations.

Studies monitored how symptoms evolved in the observed populations over defined time intervals. Research examined patient-reported outcomes describing perceived discomfort. These included outcomes capturing phases of heightened symptom activity, such as scores for pain severity and joint stiffness, as well as outcomes reflecting daily functioning, such as the assessment of physical function. Findings describe patterns observed in the studies where measurements of these symptoms data show patterns related to the short-term observation period.

Controlled and Comparator Trial Designs

The use of a vehicle control in the major studies is relevant in evidence describing how symptoms are measured. Research examined how patient outcomes differed compared to the inactive liquid preparation. Separately, studies also explored systemic parameters by comparing the topical solution to oral diclofenac. Studies monitored the amount of the active ingredient observed in the bloodstream when delivered topically.

Duration of Studies and Long-Term Follow-up

The key efficacy research was applied in studies examining short-term or episodic symptom patterns. The key controlled trials, which provide the primary comparative data, typically observed patient responses over durations of 4 to 12 weeks. Follow-up durations were limited in the controlled setting. Studies monitored outcomes for a longer duration through open-label continuation studies. These settings, where all participants received the active solution, tracked data for periods up to 12 months, where findings help contextualize how patients reported their experience over an extended timeframe.

Research in Specific Populations

Research was conducted during periods of increased symptom activity in adults with knee osteoarthritis. Studies primarily focused on populations that included older adults in the general study group, and data show patterns related to the specific outcomes monitored within these cohorts. Results apply only to the populations studied. Data for certain groups remain insufficient (research limitation frame), such as for individuals with complex conditions or specific comorbidities. Research was not conducted in pediatric populations (children), and data are not available for use in patients under 18 years of age.

Key Evidence Gaps and Areas for Further Research

Evidence contributes to the broader evidence landscape, but also highlights areas where research is ongoing. Long-term effects are not fully established, as the most definitive controlled data rely on shorter-term observation. Additionally, comparative evidence is lacking: the research did not include dedicated head-to-head trials to compare the effectiveness or functional outcomes of this specific topical solution against other commercially available topical diclofenac dosage forms (such as a gel or patch) for the management of knee osteoarthritis.

Key Studies & References

1. Product Monograph: APO-DICLOFENAC (1.5% w/w diclofenac sodium solution) Topical Anti-inflammatory
2. Does topical diclofenac relieve osteoarthritis pain? (Clinical Review and Meta-Analysis Summary)

Common questions about Pennsaid (FAQ)

---

Q: How quickly does the solution start to work after I apply it?

Studies and official information indicate that the active ingredient, diclofenac, is absorbed through the skin and can be detected in the bloodstream within approximately one hour after topical application. This absorption is related to the drug's intended effect on pain and inflammation.

---

Q: Is there a limit on how long I can use the topical solution for my knee pain?

Official regulatory documents emphasize that Nonsteroidal Anti-inflammatory Drugs (NSAIDs) should be used at the lowest effective dosage for the shortest duration possible. This general caution is consistent with the regulatory classification of NSAIDs and the need to mitigate potential risks associated with the drug class, which can occur even when the drug is applied topically.

---

Q: Can I use this product if I have a cut or rash on my knee?

Official product information states that the topical solution should not be applied to open wounds or damaged skin. Official instructions describe applying the medication to clean, intact skin on the affected knee area.

---

Q: How long after applying the solution must I wait before showering or bathing?

Official prescribing information indicates a required waiting period of at least 30 minutes before showering or bathing. This is to allow the solution to dry completely before the area is exposed to water.

---

Q: What happens if a child accidentally swallows the solution?

Accidental ingestion of NSAIDs can potentially lead to severe adverse effects, including stomach upset and neurological or kidney problems in cases of high overexposure. In the event of accidental ingestion, authoritative health bodies direct individuals to immediately contact a certified Poison Control Center for specialized guidance.

---

Q: Can I use other topical products, like sunscreens or moisturizers, on the treated area?

Official guidance indicates that the treated area must be completely dry before any other topical product is applied. This includes sunscreens, lotions, moisturizers, cosmetics, or any other topical medications.

---

Q: What should I do if the solution gets into my eyes or mouth?

The solution is strictly for external use on the skin. Official regulatory documents indicate that contact with the eyes and mucous membranes (such as the mouth) should be avoided. If accidental contact occurs, the prescribing information does not provide specific first-aid instructions.

---

Q: Can I breastfeed while using this medication?

Official regulatory information states that it is not known if diclofenac is excreted into human milk. Because topical diclofenac is an NSAID, a healthcare provider can discuss the potential risks and benefits related to use during lactation.

---

Q: Is this product considered a controlled substance?

The topical diclofenac solution is a prescription-only medication, but it is not classified as a controlled substance according to official drug classifications.

---

Q: Can I use this product on other joints, like my hands or hip?

Regulatory documents explicitly state that this product is indicated only for the treatment of pain of osteoarthritis of the knee(s). It is not indicated for use on other joints.

---

Q: What is the youngest age this solution is approved for use?

Regulatory information indicates that the safety and effectiveness in pediatric patients (children and adolescents) have not been established. Official documentation therefore does not provide an approval for use in individuals under the age of 18.

---

Q: What inactive ingredients are in the solution that could cause an allergic reaction?

Official documentation includes a contraindication for patients with a known hypersensitivity to diclofenac sodium or any other component. Information about all components is contained within the prescribing label for patient reference.

---

Q: What are the key signs of a serious side effect I should watch out for?

The official warnings for NSAIDs describe serious risks, including cardiovascular and gastrointestinal events. These warnings include descriptions of symptoms such as unusual bleeding or bruising, black or tarry stools (suggesting GI bleeding), and unusual swelling (fluid retention) or sudden weight gain.

---

Q: Is it normal to feel a tingling or warming sensation after applying?

In clinical trials and postmarketing reports, the most common adverse reactions were localized to the application site. These reported skin reactions included a burning sensation and tingling, in addition to pain, redness, and itching.

---

Q: Is this solution safer for the heart and stomach than taking an oral NSAID?

The product label contains Boxed Warnings and Precautions regarding serious cardiovascular and gastrointestinal risks, as these are class effects of all NSAIDs. The official documents indicate that the combined use of the topical solution with an oral NSAID should be avoided due to the potential for increased risks.

---

Q: What are the long-term side effects if I use this for months or years?

Serious risks associated with long-term NSAID use, even when applied topically, include an increased risk of heart attack and stroke with longer duration, as well as the potential for serious gastrointestinal bleeding, ulceration, or perforation. The regulatory guidance related to NSAIDs indicates a focus on using the medication for the shortest duration possible.

---

Q: Will this topical solution help with swelling as well as pain?

The product is officially indicated for treating the pain of osteoarthritis of the knee(s). The official label also notes that the medication may be associated with fluid retention (edema), and this caution is highlighted for patients with pre-existing heart failure.

How to Store and Dispose of Pennsaid?

Official regulatory guidelines define specific conditions for storing and disposing of Pennsaid (diclofenac sodium topical solution) to maintain its quality and prevent environmental contamination.

Official Storage Requirements

Condition	Requirement
Temperature	Store at Controlled Room Temperature (25 C), allowing excursions between 15 C and 30 C.
Environment	Protect from heat, moisture, and light. Do not freeze.
Safety	Keep the medicine out of the sight and reach of children.
Container	Store in the closed container. The 2% solution pump should be kept upright.

Disposal Instructions

Unused or expired medication must not be disposed of in wastewater (flushing down the sink or toilet) or household trash. Users are instructed to consult a pharmacist for guidance on proper disposal methods that comply with local regulatory requirements.